Vida Clinical Studies
Vida Clinical Studies is a privately held, single-site clinical research facility in Dearborn Heights, Michigan, with ~10 employees and 10+ years of experience running vaccine, interventional, and diagnostic trials for pharmaceutical sponsors and CROs by recruiting from the diverse Detroit-area community.
- Company typePrivate
- Founded-
- HeadquartersDearborn Heights, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Vida Clinical Studies does
Vida Clinical Studies is a privately held, single-site clinical research organization (SRO) headquartered at 8560 N. Silvery Lane, Suite 101, Dearborn Heights, Michigan, with approximately 10 employees and over 10 years of operating experience in the greater Detroit/Metro Detroit area. The company runs vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs), while recruiting paid study volunteers directly from the local community through its website, phone, email, and an embedded StudyPulse online booking widget. Participant compensation for active studies ranges from $150 (STD medical device study) to $3,450 (acne vaccine study), with current programs spanning RSV and pneumococcal infant vaccines, a COVID+flu vaccine study, a Phase III cardiovascular trial in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD), and COVID/flu at-home diagnostic device validation.
The company's underlying technology and facility infrastructure is built around a CLIA-certified on-site laboratory with biobanking capability (-80°C and -20°C freezers, 2-8°C refrigerators), peripheral blood mononuclear cell (PBMC) processing for immunology research, and ECG and cardiovascular diagnostic equipment to support protocol-driven assessments. Vida's core operational differentiator is its deep community engagement in the ethnically diverse Dearborn/Detroit area, which the company positions as a competitive advantage for sponsors needing representative patient populations, and which was validated externally when CRIO recognized Vida as the highest enrolling site in a high-profile vaccine study. The business model is professional-services based: revenue is generated through study contracts with pharmaceutical sponsors and CROs for participant recruitment, data collection, and regulatory compliance, while participant compensation is funded by sponsors as a pass-through component of study budgets. There is no disclosed evidence of institutional investment, parent company ownership, or multi-site expansion, and the company appears to be founder/management-owned and operated.
Vida Clinical Studies firmographics
Firmographics- Name
- Vida Clinical Studies
- Legal name
- Vida Clinical Studies
- Website
- https://vidastudies.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Vida Clinical Studies is a privately held, single-site clinical research facility in Dearborn Heights, Michigan, with ~10 employees and 10+ years of experience running vaccine, interventional, and diagnostic trials for pharmaceutical sponsors and CROs by recruiting from the diverse Detroit-area community.
- Ownership category
- akta.pro rank
Vida Clinical Studies industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ)
Keywords
Where Vida Clinical Studies is headquartered
LocationHeadquarters
- HQ city
- Dearborn Heights
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vida Clinical Studies business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Clinical Trial Services: Conduct clinical research studies on behalf of pharmaceutical sponsors and CROs. Revenue generated through study contracts for participant recruitment, data collection, and regulatory compliance.
- Study Participant Compensation: Participants receive compensation for their involvement in clinical trials, funded by pharmaceutical sponsors as part of study budgets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Acne Vaccine Study - $3,450 |
| Other | Pay-as-you-go | Migraine Study - $1,000+ |
| Other | Pay-as-you-go | Pneumococcal Infant Vaccine Study - $1,180 |
| Other | Pay-as-you-go | STD Medical Device Study - $150 |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Vida Clinical Studies product offering
Product offeringCore offering
Vida Clinical Studies operates a private clinical research facility in Dearborn Heights, Michigan, conducting paid vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and CROs. The site recruits local Detroit-area volunteers—infants, adults, and families—and delivers protocol execution using on-site CLIA-certified laboratories, biobanking freezers, PBMC processing, and ECG/cardiovascular diagnostic equipment.
Product overview
Vida Clinical Studies operates as a clinical research facility providing a unified platform of clinical trial services for pharmaceutical sponsors and CRO partners. The company offers three integrated service categories: Vaccine Studies (RSV, acne, migraine, and pneumococcal vaccines), Interventional Studies (COVID/flu vaccines and cardiovascular medications), and Diagnostic Studies (COVID/flu testing devices and STD medical devices). All services are delivered through their CLIA-certified facility in Dearborn Heights, Michigan, with on-site laboratory capabilities, diagnostic equipment, and dedicated monitoring rooms to support protocol compliance and patient enrollment.
Differentiator
Problem solved
Functional benefit
Products and services
- Vaccine Studies Clinical trials for vaccine candidates conducted at the Dearborn Heights facility for pharmaceutical sponsors and CROs. Enrolls paid volunteers including infants, children, and adults across RSV, acne, migraine, and pneumococcal vaccine protocols. Participant compensation ranges from $1,180 to $3,450 depending on study.
- Interventional Studies Clinical trials evaluating investigational medications including COVID+flu vaccine studies and a Phase III cardiovascular study assessing the effect of an oral medication on major adverse cardiovascular events in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD). Delivered to pharmaceutical sponsors and CROs.
- Diagnostic Studies Clinical trials testing diagnostic devices including COVID/flu at-home testing devices for all ages and an STD medical device study using self-collected vaginal swabs and urine samples, with $150 compensation for STD study participants aged 14+. Delivered to pharmaceutical sponsors, CROs, and device manufacturers.
Quantifiable outcome
- Highest enrolling site recognition in high-profile vaccine study
Companies that use Vida Clinical Studies
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Vida Clinical Studies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vida Clinical Studies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CRIOnotableCRIO, a clinical research technology company, recognized Vida Clinical Studies as the highest enrolling site in a high-profile vaccine study through their case study documentation. This recognition highlights Vida's excellence in patient recruitment and clinical trial execution.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Vida Clinical Studies competitors and assessment
Company assessmentPeers
Emerging players
- DM Clinical Research: Clinical research site organization with multiple U.S. locations focused on diverse patient recruitment for vaccine and therapeutic trials. Comparable to Vida in targeting underrepresented populations and operating community-rooted sites.
Direct peers
- Accel Research Sites: Multi-therapeutic clinical research site network with integrated recruitment, principal investigators, and dedicated facilities. Operates the same direct-to-consumer plus sponsor-channel model as Vida across multiple U.S. regions.
- Velocity Clinical Research: Multi-site clinical research site network operating integrated research facilities across the U.S. for pharmaceutical and CRO trials. Directly comparable to Vida as a Site Management Organization serving sponsors with similar vaccine, interventional, and diagnostic study offerings.
- Benchmark Research: Clinical research site network running vaccine, infectious disease, and therapeutic trials across multiple U.S. locations. Similar SMO profile recruiting directly to consumers while serving pharma and CRO clients.
- CenExel Clinical Research: Network of clinical research sites specializing in Phase I-IV trials across multiple therapeutic areas including vaccines and CNS. Comparable SMO model delivering site-based study execution for pharma sponsors and CROs.
Broad incumbents
- Medpace: Mid-sized global CRO running full-service clinical development including site management and clinical monitoring. Competes indirectly with Vida for sponsor protocol execution but at much broader scale across geographies and therapeutic areas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Vida Clinical Studies social profiles
Digital presenceVida Clinical Studies compliance and trust
Trust signalCompliance1 record
Vida Clinical Studies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vida Clinical Studies leadership team
Management profileNumber of profiles
Vida Clinical Studies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vida Clinical Studies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vida Clinical Studies
What does Vida Clinical Studies do?
Vida Clinical Studies operates a private clinical research facility in Dearborn Heights, Michigan, conducting paid vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and CROs. The site recruits local Detroit-area volunteers—infants, adults, and families—and delivers protocol execution using on-site CLIA-certified laboratories, biobanking freezers, PBMC processing, and ECG/cardiovascular diagnostic equipment.
Is Vida Clinical Studies a public or private company?
Vida Clinical Studies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vida Clinical Studies founded?
Vida Clinical Studies was founded in -1. It employs 1 to 10 people.
Where is Vida Clinical Studies based?
Vida Clinical Studies is headquartered in Dearborn Heights, United States, in the North America region.
How does Vida Clinical Studies make money?
Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are study Participant Compensation.
Who are Vida Clinical Studies's main competitors?
IQVIA is listed as a peer. DM Clinical Research is listed as an emerging player. Direct peers are Accel Research Sites, Velocity Clinical Research, Benchmark Research and CenExel Clinical Research. Medpace is listed as a broad incumbent.
Does Vida Clinical Studies have an API?
No public API is recorded for Vida Clinical Studies.
What industry is Vida Clinical Studies in?
Vida Clinical Studies's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 541714 and its SIC code is 8731.